ANVIGLOBE
Celltrion, Inc.
Application Filed: 2022-06-09
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79346023 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2022-06-09 | Application Filed |
| 2022-07-28 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-07-28 | Status: Live/Pending |
| 2022-07-29 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CELLTRION, INC. |
| Address | 23, Academy-ro, Yeonsu-gu Incheon 22014 KR |
| Legal Entity Type | Corporation |
| Legal Entity State | KR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations; antibody treatment preparations; pharmaceuticals; drugs for medical purposes |
| GS0051 | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of COVID-19, pharmaceutical preparations for the treatment of viral diseases, pharmaceutical preparations for the treatment of respiratory diseases, pharmaceutical preparations for the treatment of auto-immune diseases, pharmaceutical preparations for the treatment of immune diseases, pharmaceutical preparations for the treatment of inflammatory diseases, pharmaceutical preparations for use in dermatological diseases, pharmaceutical preparations for the treatment of psoriasis, pharmaceutical preparations for the treatment of arthritis, pharmaceutical preparations for the treatment of spondylitis, pharmaceutical preparations for the treatment of Multiple Sclerosis, pharmaceutical preparations for the treatment of cancer and tumor, pharmaceutical preparations for the treatment of digestive diseases, pharmaceutical preparations for the treatment of metabolic diseases, pharmaceutical preparations for the treatment of endocrine diseases, pharmaceutical preparations for the treatment of genitourinary diseases, pharmaceutical preparations for the treatment of hepatological diseases, pharmaceutical preparations for the treatment of eye diseases, pharmaceutical preparations for the treatment of musculoskeletal disorders, pharmaceutical preparations for the treatment of genetic disorders, pharmaceutical preparations for the treatment of neurological disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-07-28 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-07-29 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-08-02 | 3 MAFR O:Outgoing Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-11-08 | 4 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-11-08 | 5 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-11-08 | 6 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-11-08 | 7 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-11-08 | 8 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-11-08 | 9 CHAN I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2023-03-13 | 10 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-03-16 | 11 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-03-17 | 12 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-05-05 | 13 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-05-05 | 14 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-05-31 | 15 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-09-07 | 16 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-09-07 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-09-08 | 18 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-09-13 | 19 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-09-27 | 20 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-09-27 | 21 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-09-27 | 22 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2023-10-16 | 23 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2023-10-17 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-10-17 | 25 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2024-01-02 | 26 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-01-02 | 27 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-04-02 | 28 FICR P: |
| FINAL DISPOSITION PROCESSED | 2024-04-09 | 29 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2024-04-09 | 30 FICS P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 